Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Psychological and psychiatric aspects of treatment of obesity and nonalcoholic fatty liver disease.

Stewart KE, Levenson JL.

Clin Liver Dis. 2012 Aug;16(3):615-29. doi: 10.1016/j.cld.2012.05.007. Epub 2012 Jun 26. Review.

2.

Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.

Gracious BL, Bhatt R, Potter C.

J Child Adolesc Psychopharmacol. 2015 Oct;25(8):602-10. doi: 10.1089/cap.2015.0007. Epub 2015 Oct 8. Review.

PMID:
26447642
3.

The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat.

Abidov M, Ramazanov Z, Seifulla R, Grachev S.

Diabetes Obes Metab. 2010 Jan;12(1):72-81. doi: 10.1111/j.1463-1326.2009.01132.x. Epub 2009 Oct 13.

PMID:
19840063
4.

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA.

Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575.

PMID:
19053049
5.

Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.

Pallayova M, Taheri S.

Clin Obes. 2014 Oct;4(5):243-53. doi: 10.1111/cob.12068. Epub 2014 Jul 28. Review.

PMID:
25825857
6.

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.

Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, Leshno M, Blendis L, Halpern Z, Oren R.

Clin Gastroenterol Hepatol. 2006 May;4(5):639-44. Epub 2006 Apr 17.

PMID:
16630771
8.

Weight loss as a treatment for nonalcoholic fatty liver disease.

Clark JM.

J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S39-43. Review.

PMID:
16540766
9.

Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.

Smith BW, Adams LA.

Nat Rev Endocrinol. 2011 May 10;7(8):456-65. doi: 10.1038/nrendo.2011.72. Review.

PMID:
21556019
10.

Current pharmacological treatment of nonalcoholic fatty liver.

Portincasa P, Grattagliano I, Palmieri VO, Palasciano G.

Curr Med Chem. 2006;13(24):2889-900. Review.

PMID:
17073635
11.

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D, Sattar N, Fraser A, Waugh N.

Health Technol Assess. 2011 Nov;15(38):1-110. doi: 10.3310/hta15380. Review.

12.

Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.

Williams T.

FP Essent. 2015 Aug;435:24-9. Review.

PMID:
26280342
13.

The treatment of NAFLD.

Trappoliere M, Tuccillo C, Federico A, Di Leva A, Niosi M, D'Alessio C, Capasso R, Coppola F, Dauria M, Loguercio C.

Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):299-304. Review.

PMID:
16231594
14.

Managing comorbid obesity and depression through clinical pharmacotherapies.

McElroy SL, Guerdjikova AI, Mori N, Keck PE.

Expert Opin Pharmacother. 2016 Aug;17(12):1599-610. doi: 10.1080/14656566.2016.1198776. Epub 2016 Jun 24. Review.

PMID:
27280311
15.

[Bipolar disorders and comorbid anxiety: prognostic impact and therapeutic challenges].

Cazard F, Ferreri F.

Encephale. 2013 Feb;39(1):66-74. doi: 10.1016/j.encep.2012.04.005. Epub 2012 Jun 15. Review. French.

PMID:
23095585
16.

Effects of weight loss on nonalcoholic fatty liver disease.

Rafiq N, Younossi ZM.

Semin Liver Dis. 2008 Nov;28(4):427-33. doi: 10.1055/s-0028-1091986. Epub 2008 Oct 27. Review.

PMID:
18956298
17.

Treatment of binge eating disorder.

Wilson GT.

Psychiatr Clin North Am. 2011 Dec;34(4):773-83. doi: 10.1016/j.psc.2011.08.011. Epub 2011 Oct 5.

PMID:
22098803
18.

Effect of weight loss on nonalcoholic fatty liver disease.

Patel AA, Torres DM, Harrison SA.

J Clin Gastroenterol. 2009 Nov-Dec;43(10):970-4. doi: 10.1097/MCG.0b013e3181b57475. Review.

PMID:
19727004
19.

Psychosocial outcomes for children with nonalcoholic fatty liver disease over time and compared with obese controls.

Kerkar N, D'Urso C, Van Nostrand K, Kochin I, Gault A, Suchy F, Miloh T, Arnon R, Chu J, Annunziato R.

J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):77-82. doi: 10.1097/MPG.0b013e31826f2b8c.

PMID:
22925921
20.

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Younossi ZM.

Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Review.

Supplemental Content

Support Center